Agilent

历史时间线

• 1999: Spun off from Hewlett-Packard's test & measurement division
• 2000: Goes public, focuses on life sciences and diagnostics
• 2005: Spins off semiconductor products as Advantest
• 2010s: Shifts focus entirely to life sciences and applied markets
• 2014: Acquires BioTek for $1.2B, enters microplate readers
• 2017: Acquires ACEA Biosciences, adds cell analysis
• 2021: Revenue hits $6.5B post-pandemic lab spending surge
• 2023: $6.9B revenue, strong recurring consumables revenue

商业模式

Three segments: Lifesciences & Diagnostics (instruments, consumables, services), Applied Markets (food, environmental, forensics, pharma QC), Agilent CrossLab (lab services, informatics). Razor-and-blades model: instruments generate recurring high-margin consumables and service revenue.

护城河分析

Installed base of 500,000+ instruments creates decades-long consumables revenue stream. Regulatory validation — Agilent instruments are the 'gold standard' for FDA-regulated labs. CrossLab services create sticky customer relationships.

关键数据

• Founded: 1999 (HP spinoff), Santa Clara, California
• Revenue 2023: $6.9B
• Employees: ~18,000
• Market Cap: ~$38B
• Installed Base: 500,000+ instruments

有趣事实

• Agilent's origin as an HP spin-off means it inherited HP's legendary engineering culture — co-founder Bill Hewlett's 'HP Way' management philosophy still influences the company.
• During the pandemic, Agilent's instruments were critical for mRNA vaccine development — their mass spectrometry and chromatography systems characterized vaccine components.